CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 109 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $253 | -31.4% | 11,600 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $369 | +67.7% | 11,600 | +28.9% | 0.00% | +100.0% |
| Q1 2023 | $220 | -22.5% | 9,000 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $284 | -99.9% | 9,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $254,000 | +10.4% | 9,000 | +3.4% | 0.00% | +100.0% |
| Q2 2022 | $230,000 | -36.3% | 8,700 | -15.5% | 0.00% | -50.0% |
| Q1 2022 | $361,000 | +8.1% | 10,300 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $334,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |